Projects

Mgr. Nataliia Nikolaieva, PhD.

National

Current
  • Study of Gut Microbiome Modulation by Butyrate Administration in Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation or CAR-T Cell Therapy.
    Program: VEGA
    Duration: 1. 1. 2026 – 31. 12. 2029
  • Impact of the gut microbiome on the treatment and prognosis of patients with testicular germ cell tumors.
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • The emerging role of the microbiome in hematologic cancer patients receiving high-dose chemotherapy with hematopoietic stem cell transplantation.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Regulation of epithelial-mesenchymal transition by microRNA and promoter methylation in invasive breast cancer
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
Employees